← back to search

Li Fu

Energy Institute · GB
Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include RNA modifications and cancer, Cancer-related gene regulation, Epigenetics and DNA Methylation, and MicroRNA in disease regulation.
h-index
60
citations
11,850
works
385
NIH funding
primary concept
email

Recent publications

Immune characteristics of olfactory ensheathing cells and repair of nerve injury
Frontiers in Immunology 2025cited by 3position: lastdoi
Diabetes is causally associated with increased breast cancer mortality by inducing FIBCD1 to activate MCM5-mediated cell cycle arrest via modulating H3K27ac
Cell Death and Disease 2025cited by 1position: middledoi
ATP6V0A1-dependent cholesterol absorption in colorectal cancer cells triggers immunosuppressive signaling to inactivate memory CD8+ T cells
Nature Communications 2024cited by 36position: lastdoi
Neoantigens: promising targets for cancer therapy
Signal Transduction and Targeted Therapy 2023cited by 896position: lastdoi
WNT2–SOX4 positive feedback loop promotes chemoresistance and tumorigenesis by inducing stem-cell like properties in gastric cancer
Oncogene 2023cited by 45position: lastdoi
Targeting MFGE8 secreted by cancer-associated fibroblasts blocks angiogenesis and metastasis in esophageal squamous cell carcinoma
Proceedings of the National Academy of Sciences 2023cited by 42position: middledoi
Endothelial extracellular vesicles induce acute lung injury via follistatin-like protein 1
Science China Life Sciences 2023cited by 29position: middledoi
Targeting LGSN restores sensitivity to chemotherapy in gastric cancer stem cells by triggering pyroptosis
Cell Death and Disease 2023cited by 19position: lastdoi
Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management
Journal of Hematology & Oncology 2022cited by 243position: lastdoi
Targeting TROY-mediated P85a/AKT/TBX3 signaling attenuates tumor stemness and elevates treatment response in hepatocellular carcinoma
Journal of Experimental & Clinical Cancer Research 2022cited by 37position: middledoi
PDGFRβ is an essential therapeutic target for BRCA1-deficient mammary tumors
Breast Cancer Research 2021cited by 23position: middledoi
Squalene epoxidase drives NAFLD-induced hepatocellular carcinoma and is a pharmaceutical target
Science Translational Medicine 2018cited by 276position: middledoi
Frizzled7 Promotes Epithelial-to-mesenchymal Transition and Stemness Via Activating Canonical Wnt/β-catenin Pathway in Gastric Cancer
International Journal of Biological Sciences 2018cited by 116position: middledoi
Epigenetic alterations of a novel antioxidant gene <i>SLC22A3</i> predispose susceptible individuals to increased risk of esophageal cancer
International Journal of Biological Sciences 2018cited by 29position: lastdoi
O-GlcNAc transferase promotes fatty liver-associated liver cancer through inducing palmitic acid and activating endoplasmic reticulum stress
Journal of Hepatology 2017cited by 148position: middledoi
RNA editing of <i>SLC22A3</i> drives early tumor invasion and metastasis in familial esophageal cancer
Proceedings of the National Academy of Sciences 2017cited by 105position: firstdoi
Integrin α7 is a functional cancer stem cell surface marker in oesophageal squamous cell carcinoma
Nature Communications 2016cited by 105position: middledoi
Hypoxia inhibits pulmonary artery endothelial cell apoptosis via the e-selectin/biliverdin reductase pathway
Microvascular Research 2016cited by 11position: middledoi
Increased Expression of EIF5A2, Via Hypoxia or Gene Amplification, Contributes to Metastasis and Angiogenesis of Esophageal Squamous Cell Carcinoma
Gastroenterology 2014cited by 112position: middledoi
Frequent Mutation of rs13281615 and Its Association with PVT1 Expression and Cell Proliferation in Breast Cancer
Journal of genetics and genomics/Journal of Genetics and Genomics 2014cited by 36position: middledoi
Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma
Nature Medicine 2013cited by 540position: middledoi
A CD90+ Tumor-Initiating Cell Population with an Aggressive Signature and Metastatic Capacity in Esophageal Cancer
Cancer Research 2013cited by 148position: middledoi
Characterization of Tumor Suppressive Function of cornulin in Esophageal Squamous Cell Carcinoma
PLoS ONE 2013cited by 104position: middledoi
Cell-Specific Detection of miR-375 Downregulation for Predicting the Prognosis of Esophageal Squamous Cell Carcinoma by miRNA In Situ Hybridization
PLoS ONE 2013cited by 64position: middledoi
MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN
Carcinogenesis 2012cited by 190position: lastdoi
RBMS3 at 3p24 Inhibits Nasopharyngeal Carcinoma Development via Inhibiting Cell Proliferation, Angiogenesis, and Inducing Apoptosis
PLoS ONE 2012cited by 63position: middledoi
Chromodomain helicase DNA binding protein 5 plays a tumor suppressor role in human breast cancer
Breast Cancer Research 2012cited by 49position: middledoi

Grants

Learning Critical Discriminants and Descriptors in Data Mining
NSF0221954$200,0002002–2005PIRePORTER
Probabilistic Learning Neural Networks for Knowledge and Data Acquisition
NSF9615909$184,3271997–2001PIRePORTER
SGER: Machine Learning by Combining Knowledge and Adaptation
NSF9707333$18,0241997–1998PIRePORTER
Machine Learning by Combining Knowledge and Adaptation
NSF9214141$167,6941993–1996PIRePORTER

Frequent collaborators

Xin‐Yuan Guan · Chongqing Jiaotong University11 papers (2012–2023) · 4 papers (2012–2017) · 4 papers (2012–2023)Yanru Qin · Guangxi University4 papers (2013–2018)Ting-Ting Cao · Shenzhen University3 papers (2014–2017)Haibo Liu · Jiangsu University3 papers (2013–2018)Stephanie Ma · University of Hong Kong3 papers (2013–2023)Dan Xie · Capital Medical University3 papers (2014–2017)Huahui Li · Soochow University3 papers (2023–2024)Tu-Xiong Huang · Shenzhen University3 papers (2017–2024)Sui-Sui Dong · Sun Yat-sen University Cancer Center3 papers (2012–2017)Ming Liu · Yangtze University2 papers (2012–2013)Yuting Li · Nanjing University of Chinese Medicine2 papers (2023–2023)Jun Yu · University of Geneva2 papers (2017–2018)Leilei Chen · National University of Singapore2 papers (2012–2013)Zhiqian Zhang · The University of Texas MD Anderson Cancer Center2 papers (2012–2014)Jie Luo · Fujian Agriculture and Forestry University2 papers (2022–2023)Bin-Bin Tan · Shenzhen University2 papers (2017–2018)Jiong Bi · Sun Yat-sen University2 papers (2018–2024)Beilei Liu · City University of Hong Kong2 papers (2022–2023)